Boehringer Ingelheim International is a global pharmaceutical company engaged in human pharmaceuticals, animal health, and biopharmaceuticals businesses. It focuses on researching medicines and offering therapies for diseases for which satisfactory treatment options are currently unavailable and provides the entire value chain, starting from research and development through the production and commercialization of its products. The company provides treatments for cardiovascular and metabolic diseases, oncology, diseases of the central nervous system, infectious diseases, as well as veterinary vaccines and medicines, and a variety of biopharmaceuticals. 